Looking to publish in Cell Reports Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCell Reports Medicine is a premium open-access Cell Press journal publishing translational and clinical biomedical research that informs human health and medicine. It publishes original research across human biology, health, disease, clinical work, translational studies, clinical trials, genomics, biomarker discovery, diagnostic and healthcare technologies, and directly relevant vertebrate model organism studies, along with reports, articles, tools, datasets, and reviews.
Looking to publish in Cell Reports Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Cell Reports Medicine accepts the following article types. Click on an article type to view submission instructions.
Report
Research Article
Review
Recent Publications
Subretinal rAAV2-based VEGF-Trap gene therapy for neovascular age-related macular degeneration: Preclinical assessment and phase 1 trial results
Tong Li, Jingyang Feng, Xiaolu Yang, Shiqi Yang, Jieqiong Chen, Yidong Wu, Xiaosa Li, Zhuoyu Ni, Yang Liu, Minlu Song, Peirong Huang, Kairong Zheng, Hong Wang, Xian Xu, Junran Sun, Fenghua Wang, Huixun Jia, Xiaodong Sun
Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats
Josh Allen, Bianca Jupp, Tamara L. Baker, Mohammad B. Haskali, Robert Brkljača, Zoe Plummer, Mujun Sun, Justin Brand, Brian R. Christie, Chantel T. Debert, Stuart J. McDonald, Terence J. O’Brien, Pablo M. Casillas-Espinosa, Sandy R. Shultz
Toward generalizable prediction of cancer signal using a cell-free DNA language model
Yang Xu, Hua Bao, Daxin Huang, Kun Zhang, Junfei Zhu, Liu Yang, Shengling Fu, Zhili Chang, Jinfeng Zhang, Shuang Chang, Baihan Zhu, Shuyu Wu, Shanshan Yang, Xue Wu, Yang Shao
Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative breast cancer
Meixi Hao, Qifan Hu, Xiuqi Li, Yijun Chen, Siyuan Hou, Chunjing Han, Sijia Chen, Yanyi Li, Kaiming Li, Lingjing Xue, Lulu Zhu, Shanshan Chen, Caoyun Ju, Can Zhang
Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma
Jisu Park, Meiyu Qiu, Eun Jeong Cho, Sanghee Seo, Ji-Hoon Moon, Minji Kim, Hyemin Mun, Hyounji Yun, Hoewon Park, Arim Lim, Younsoo Kang, Jeong-woo Oh, Heejeong Youk, Seon-Hwan Kim, Yeongbeom Seo, Sae Min Kwon, Kyoung Su Sung, Hyuk-Jin Oh, Kyung Rae Cho, Kyungtae Yoon, Nam-Shik Kim, Se Jin Jang, Kyung Hwan Kim, Ki-Jun Yoon
Frequently asked questions
How long does it take to publish?
6 days submission to first decision; 43 days submission to decision after review; 205 days submission to acceptance; 27 days acceptance to online publication.
Reformat to Cell Reports Medicine using Livewrite PremiumIs a cover letter required?
A cover letter is included among the materials to prepare for submission.
Reformat to Cell Reports Medicine using Livewrite PremiumWhat are the publication costs?
Elsevier journals publish under subscription and open access models. APCs are set per journal and range between approximately $200 and $11,400 USD excluding tax, with waivers and discounts available in some cases.
Reformat to Cell Reports Medicine using Livewrite Premium